image
RedHill Biopharma Ltd. RDHL
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IL
Watchlist
$ 2.31
-3.98 %
$ 10.6 K
Market Cap
-0.01
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
529.12%
EBIT Estimate
--91.27%
Net Income Estimate
100.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets RedHill Biopharma Ltd.
image
RDHL has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart RDHL

image
$90.0m$90.0m$80.0m$80.0m$70.0m$70.0m$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026
EBIT FORECAST

EBIT Forecast Chart RDHL

image
$40.0m$40.0m$20.0m$20.0m$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026
NET INCOME FORECAST

Net Income Chart RDHL

image
$2.0b$2.0b$0.0$0.0($2.0b)($2.0b)($4.0b)($4.0b)($6.0b)($6.0b)($8.0b)($8.0b)($10.0b)($10.0b)($12.0b)($12.0b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026